Table 1.
Incidence | More common in older women. 4.5% incidence in women age <40138 |
Presentation | More advanced in younger women, more diagnostic delays10,11 |
Biology | High frequency of HR-negative disease29 |
Genetics | As younger women are more likely to have inherited susceptibility, genetic testing is recommended for all patients ≤40 years |
Prognosis | Inferior outcome in younger patients45,57,58 |
Unique considerations | Premature ovarian failure, reduced fertility, increased social stressors from raising young children and active workforce participation, prolonged survivorship period, bone loss |
Abbreviation: HR, hormone receptor.